AMAL(AMAL)
AMAL
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $378M | $404M |
| Low | $378M | $403M |
| High | $378M | $404M |
| EBITDA Avg | $135M | $144M |
| Low | $135M | $144M |
| High | $135M | $144M |
| EBIT Avg | $128M | $136M |
| Low | $127M | $136M |
| High | $128M | $136M |
| Net Income Avg | $121M | $139M |
| Low | $121M | $139M |
| High | $121M | $140M |
| EPS Avg | $4.00 | $4.61 |
| Low | $3.99 | $4.60 |
| High | $4.01 | $4.61 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $96M | $96M | $96M | $99M | $103M | $106M |
| Low | $96M | $96M | $96M | $99M | $103M | $106M |
| High | $96M | $97M | $96M | $99M | $103M | $106M |
| EBITDA Avg | $34M | $34M | $34M | $35M | $37M | $38M |
| Low | $34M | $34M | $34M | $35M | $37M | $38M |
| High | $34M | $35M | $34M | $36M | $37M | $38M |
| EBIT Avg | $32M | $33M | $32M | $33M | $35M | $36M |
| Low | $32M | $32M | $32M | $33M | $35M | $36M |
| High | $33M | $33M | $32M | $34M | $35M | $36M |
| Net Income Avg | $32M | $32M | $31M | $33M | $36M | $38M |
| Low | $32M | $32M | $31M | $33M | $36M | $38M |
| High | $32M | $32M | $31M | $33M | $36M | $38M |
| EPS Avg | $1.07 | $1.07 | $1.03 | $1.10 | $1.19 | $1.25 |
| Low | $1.07 | $1.07 | $1.03 | $1.10 | $1.18 | $1.25 |
| High | $1.07 | $1.07 | $1.04 | $1.10 | $1.19 | $1.26 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |